# Key Insights Summary

- GSK maintained strong profitability despite weaker short-term liquidity.
- 2022 showed improved operational efficiency following the consumer healthcare demerger.
- Gross profit margins increased steadily, indicating better cost control.
- Liquidity ratios remained below ideal levels, suggesting reliance on working capital management.
- High payable days indicate strong cash retention but potential supplier risk.
- Shareholder confidence remained strong despite dividend volatility.
